Evidence map›Paper›PMID 28968510›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Molecular diagnosis of symptomatic toxoplasmosis: a 9-year retrospective and prospective study in a referral laboratory in São Paulo, Brazil.

Lilian Muniz Camilo, Vera Lucia Pereira-Chioccola, Ricardo Gava, Cristina da Silva Meira-Strejevitch, Jose Ernesto Vidal, Cinara Cássia Brandão de Mattos, Fábio Batista Frederico, Luiz Carlos De Mattos, Lígia Cosentino Junqueira Franco Spegiorin, FAMERP Toxoplasma Research Group

Abstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. The Role of microRNAs in the Infection byFrontiers in cellular and infection microbiology · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Evaluation of Serological and Molecular Tests Used for the Identification ofFrontiers in cellular and infection microbiology · 2019
    Article
  9. Serum IgG Anti-Frontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lilian Muniz CamiloCentro de Parasitologia e Micologia, Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Vera Lucia Pereira-ChioccolaCentro de Parasitologia e Micologia, Instituto Adolfo Lutz, São Paulo, SP, Brazil. Electronic address: pchioccola@gmail.com.
Ricardo GavaCentro de Parasitologia e Micologia, Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Cristina da Silva Meira-StrejevitchCentro de Parasitologia e Micologia, Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Jose Ernesto VidalInstituto de Infectologia Emilio Ribas, São Paulo, SP, Brazil; Faculdade de Medicina, Hospital das Clínicas, da Universidade de São Paulo, São Paulo, SP, Brazil; Laboratório de Investigação Médica (LIM) 49, Instituto de Medicina Tropical da Universidade de São Paulo, São Paulo, SP, Brazil.
Cinara Cássia Brandão de MattosFaculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil.
Fábio Batista FredericoAmbulatório de Oftalmologia, Fundação Faculdade Regional de Medicina-Hospital de Base, São José do Rio Preto, SP, Brazil.
Luiz Carlos De MattosFaculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil.
Lígia Cosentino Junqueira Franco SpegiorinFaculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil; Hospital da Criança e Maternidade, São José do Rio Preto, SP, Brazil.
FAMERP Toxoplasma Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Symptomatic forms of toxoplasmosis are a serious public health problem and occur in around 10-20% of the infected people. Aiming to improve the molecular diagnosis of symptomatic toxoplasmosis in Brazilian patients, this study evaluated the performance of real time PCR testing two primer sets (B1 and REP-529) in detecting Toxoplasma gondii DNA. The methodology was assayed in 807 clinical samples with known clinical diagnosis, ELISA, and conventional PCR results in a 9-year period. All samples were from patients with clinical suspicion of several features of toxoplasmosis. According to the minimum detection limit curve (in C

Indexed as

DNA PrimersDNA, ProtozoanHumansProspective StudiesReal-Time Polymerase Chain ReactionRetrospective StudiesSensitivity and SpecificityToxoplasmaToxoplasmosisDNA PrimersDNA, ProtozoanDiagnosisReal-time polymerase chain reactionSymptomatic toxoplasmosisToxoplasma gondii

Identifiers

PMID28968510
PMCPMC9425505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.